Are covid vaccines safe for pregnant women?
Pro Research Analysisby 
Searched over 200M research papers
Safety of COVID-19 Vaccines for Pregnant Women
Introduction to COVID-19 Vaccination in Pregnancy
The safety of COVID-19 vaccines for pregnant women has been a significant concern, given the increased risk of severe outcomes from COVID-19 during pregnancy. This article synthesizes findings from multiple studies to provide a comprehensive overview of the safety and effectiveness of COVID-19 vaccines for pregnant women.
Effectiveness of COVID-19 Vaccines in Pregnant Women
Prevention of SARS-CoV-2 Infection and Hospitalization
COVID-19 vaccines have been shown to be effective in preventing SARS-CoV-2 infection and COVID-19-related hospitalization among pregnant women. A systematic review and meta-analysis found that vaccination reduced the risk of infection (OR = 0.50) and hospitalization (OR = 0.50)1. Additionally, mRNA vaccines specifically were found to significantly reduce the risk of infection (OR = 0.13)1.
Maternal and Fetal Antibody Responses
Studies have demonstrated that mRNA vaccines (Pfizer-BioNTech and Moderna) elicit strong maternal antibody responses, which are further enhanced after a booster dose. These antibodies are effectively transferred to the fetus, providing neonatal protection2. Longer intervals between vaccination and delivery are associated with higher fetal antibody levels2.
Safety of COVID-19 Vaccines in Pregnancy
General Safety and Adverse Events
Multiple studies have confirmed the safety of COVID-19 vaccines during pregnancy. Common adverse reactions include injection site pain, fatigue, and headache, which are generally mild and transient2 3. No significant safety signals have been identified, and the rates of adverse pregnancy and neonatal outcomes are comparable to those observed before the pandemic3 4.
Specific Pregnancy and Neonatal Outcomes
Research has shown that COVID-19 vaccination during pregnancy is not associated with an increased risk of adverse outcomes such as preterm birth, congenital anomalies, or neonatal death4 5 8. A meta-analysis found no significant association between vaccination and adverse maternal or neonatal outcomes, including miscarriage, stillbirth, and low birth weight8.
Longitudinal and Real-World Evidence
Preliminary findings from large-scale surveillance systems in the United States, such as the "v-safe after vaccination health checker" and the Vaccine Adverse Event Reporting System (VAERS), support the safety of mRNA vaccines in pregnant women. These systems have not identified any new safety concerns, and the observed rates of adverse outcomes are consistent with pre-pandemic data3 5.
Vaccine Uptake and Hesitancy
Despite the demonstrated safety and effectiveness, vaccine uptake among pregnant women remains low, with only 27.5% of pregnant women globally having received the vaccine as of early 20226. Factors influencing vaccine uptake include age, ethnicity, trust in vaccines, and concerns about vaccine safety6. Targeted information campaigns are essential to improve vaccine acceptance among pregnant women.
Conclusion
The current body of evidence strongly supports the safety and effectiveness of COVID-19 vaccines for pregnant women. Vaccination not only protects pregnant women from severe COVID-19 outcomes but also provides neonatal immunity through antibody transfer. Continued efforts are needed to address vaccine hesitancy and improve vaccination rates among pregnant women to ensure their health and that of their newborns.
Sources and full results
Most relevant research papers on this topic
Effectiveness and Safety of COVID-19 Vaccine among Pregnant Women in Real-World Studies: A Systematic Review and Meta-Analysis
COVID-19 vaccines are effective and safe for pregnant women, preventing infection and related hospitalization without adverse events.
Meta-Analysis
Rigorous JournalmRNA Covid-19 vaccines in pregnancy: A systematic review
SARS-CoV-2 mRNA vaccines are a safe option for pregnant women and their fetuses, with two doses recommended for more robust maternal and fetal antibody responses.
Systematic ReviewRigorous JournalPreliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons
Preliminary findings show no obvious safety signals among pregnant persons receiving mRNA Covid-19 vaccines, but more longitudinal follow-up is needed to confirm maternal, pregnancy, and infant outcomes.
Observational StudyRigorous Journal
Highly CitedSafety of COVID-19 vaccines during pregnancy: A systematic review and meta-analysis
COVID-19 vaccines during pregnancy show no association with adverse outcomes, regardless of the vaccine or trimester of vaccination.
Meta-AnalysisPreliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons.
Pregnant women experienced more injection site pain than nonpregnant women, but no pregnancy-related adverse events were reported.
Observational StudyRigorous JournalHighly CitedUptake of COVID-19 Vaccines among Pregnant Women: A Systematic Review and Meta-Analysis
The global COVID-19 vaccination prevalence in pregnant women is low, with factors like age, ethnicity, trust in vaccines, and fear of COVID-19 influencing their decision to be vaccinated.
Meta-AnalysisRigorous JournalCOVID-19 vaccination in pregnant and lactating women: a systematic review
COVID-19 vaccines are safe and effective for pregnant and lactating women and their newborns, with no reported adverse effects or differences in reactogenicity compared to the general population.
Systematic ReviewAssociations of COVID-19 vaccination during pregnancy with adverse neonatal and maternal outcomes: A systematic review and meta-analysis
COVID-19 vaccination during pregnancy is not associated with adverse neonatal or maternal outcomes.
Meta-AnalysisCovid-19 vaccination and pregnancy: a systematic review of maternal and neonatal outcomes
SARS Cov-2 vaccination in pregnant women is effective and safe, with a 43% reduction in infections compared to unvaccinated women.
Systematic ReviewReceipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth — Eight Integrated Health Care Organizations, United States, December 15, 2020–July 22, 2021
COVID-19 vaccination during pregnancy is not associated with increased risks of preterm birth or small-for-gestational-age at birth compared to unvaccinated pregnant women.
Observational StudyHighly Cited